Alves C, von Dippe P, Amoui M, Levy D
Department of Biochemistry, School of Medicine, University of Southern California, Los Angeles 90033.
J Biol Chem. 1993 Sep 25;268(27):20148-55.
Bile acids, such as taurocholate, have been shown to be transported into hepatocyte smooth endoplasmic reticulum (SER) vesicles. This process is Na(+)-independent, electrogenic, inhibitable by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and taurochenodeoxycholate, with a Km of 352 microM and a Vmax of 29.6 nmol/mg protein/min. The observed transport is mediated by the bifunctional protein, microsomal epoxide hydrolase (mEH) which can also mediate bile acid transport into hepatocytes across the sinusoidal plasma membrane (von Dippe, P., Amoui, M., Alves, C., and Levy, D. (1993) Am. J. Physiol. 264, G528-G534). mEH was isolated from SER membranes by immunoprecipitation with monoclonal antibody (mAb) 25D-1 which recognizes this protein on the surface of intact hepatocytes. The SER-derived protein exhibited an apparent molecular weight, isoelectric point, N-terminal amino acid sequence, and mEH-specific activity that were indistinguishable from the plasma membrane form of the enzyme. Proteoliposome reconstitution of the SER taurocholate transport system indicated that mEH was absolutely required for the expression of transport capacity. The interaction of mAb 25D-1 with mEH on intact right-side-out SER vesicles demonstrated that the epitope found on the surface of hepatocytes was also found on the cytoplasmic surface of these vesicles (80%) and in the lumen (20%) suggesting the presence of two forms of this protein in the SER, the latter from being sorted to the cell surface. The existence of two orientations of this protein in the SER was confirmed by the sensitivity to tryptic digestion, where 75% of the mAb epitope was accessible to the enzyme. The loss of the 25D-1 epitope correlated with loss of taurocholate transport capacity. The role of mEH in the transport process and the orientation of the transporting isoform was further established by demonstrating that mAb 25A-3, which also reacts with mEH on the hepatocyte surface, was able to directly inhibit taurocholate transport in the SER vesicle system. These and previous results thus establish that isoforms of mEH can mediate taurocholate transport at the sinusoidal plasma membrane and in SER vesicles and that this bifunctional protein can exist in two orientations in the SER membrane. The association of bile acids with the SER suggests a possible role of intracellular vesicles in the transhepatocellular movement of bile acids from the sinusoidal to the canalicular compartment.
胆汁酸,如牛磺胆酸盐,已被证明可转运至肝细胞滑面内质网(SER)囊泡中。此过程不依赖于Na⁺,是电驱动的,可被4,4'-二异硫氰基芪-2,2'-二磺酸和牛磺鹅去氧胆酸盐抑制,其Km为352微摩尔,Vmax为29.6纳摩尔/毫克蛋白质/分钟。观察到的转运由双功能蛋白微粒体环氧化物水解酶(mEH)介导,该酶也可介导胆汁酸通过肝血窦质膜转运进入肝细胞(冯·迪普,P.,阿莫伊,M.,阿尔维斯,C.,和利维,D.(1993年)《美国生理学杂志》264卷,G528 - G534页)。通过用识别完整肝细胞表面该蛋白的单克隆抗体(mAb)25D - 1进行免疫沉淀,从SER膜中分离出mEH。从SER衍生的蛋白表现出的表观分子量、等电点、N端氨基酸序列和mEH特异性活性与该酶的质膜形式无法区分。SER牛磺胆酸盐转运系统的蛋白脂质体重组表明,mEH对于转运能力的表达是绝对必需的。mAb 25D - 1与完整的外翻SER囊泡上的mEH相互作用表明,在肝细胞表面发现的表位也存在于这些囊泡的胞质表面(80%)和腔内(20%),这表明在SER中存在该蛋白的两种形式,后者被分选到细胞表面。通过对胰蛋白酶消化的敏感性证实了该蛋白在SER中存在两种取向,其中75%的mAb表位可被该酶识别。25D - 1表位的丧失与牛磺胆酸盐转运能力的丧失相关。通过证明同样与肝细胞表面的mEH反应的mAb 25A - 3能够直接抑制SER囊泡系统中的牛磺胆酸盐转运,进一步确定了mEH在转运过程中的作用以及转运同工型的取向。因此,这些及先前的结果证实,mEH同工型可介导肝血窦质膜和SER囊泡中的牛磺胆酸盐转运,并且这种双功能蛋白在SER膜中可存在两种取向。胆汁酸与SER的结合表明细胞内囊泡在胆汁酸从肝血窦到胆小管腔的跨肝细胞转运中可能发挥作用。